Nature's Sunshine Products (NATR) Competitors

Nature's Sunshine Products logo
$20.99 +0.32 (+1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$20.83 -0.16 (-0.76%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NATR vs. HLF, USNA, NUS, MED, and VERU

Should you buy Nature's Sunshine Products stock or one of its competitors? MarketBeat compares Nature's Sunshine Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nature's Sunshine Products include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does Nature's Sunshine Products compare to Herbalife?

Herbalife (NYSE:HLF) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

79.4% of Nature's Sunshine Products shares are held by institutional investors. 5.1% of Herbalife shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Herbalife has higher revenue and earnings than Nature's Sunshine Products. Herbalife is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herbalife$5.04B0.26$228.30M$2.285.48
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.08

Herbalife has a net margin of 4.67% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
Herbalife4.67% -41.47% 8.24%
Nature's Sunshine Products 4.06%14.67%9.27%

Herbalife has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

In the previous week, Nature's Sunshine Products had 3 more articles in the media than Herbalife. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 1 mentions for Herbalife. Nature's Sunshine Products' average media sentiment score of 0.75 beat Herbalife's score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Herbalife
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nature's Sunshine Products
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Herbalife currently has a consensus price target of $17.80, suggesting a potential upside of 42.40%. Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 66.75%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Herbalife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herbalife
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Nature's Sunshine Products beats Herbalife on 9 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

USANA Health Sciences has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences0.96% 6.21% 4.50%
Nature's Sunshine Products 4.06%14.67%9.27%

Nature's Sunshine Products has lower revenue, but higher earnings than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.41$10.76M$0.4744.13
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.08

In the previous week, Nature's Sunshine Products had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 2 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 0.75 beat USANA Health Sciences' score of 0.71 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
USANA Health Sciences
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nature's Sunshine Products has a consensus price target of $35.00, indicating a potential upside of 66.75%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Nu Skin Enterprises has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Nature's Sunshine Products has a consensus price target of $35.00, indicating a potential upside of 66.75%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 4.6%. Nature's Sunshine Products pays an annual dividend of $0.40 per share and has a dividend yield of 1.9%. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Nature's Sunshine Products pays out 36.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nu Skin Enterprises is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Nature's Sunshine Products 4.06%14.67%9.27%

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Nature's Sunshine Products had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 0 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 0.75 beat Nu Skin Enterprises' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Overall Sentiment
Nu Skin Enterprises Neutral
Nature's Sunshine Products Positive

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.78
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.08

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 11 of the 17 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Medifast?

Medifast (NYSE:MED) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Nature's Sunshine Products has a net margin of 4.06% compared to Medifast's net margin of -5.78%. Nature's Sunshine Products' return on equity of 14.67% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Medifast-5.78% -4.80% -3.83%
Nature's Sunshine Products 4.06%14.67%9.27%

In the previous week, Nature's Sunshine Products had 4 more articles in the media than Medifast. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 0 mentions for Medifast. Nature's Sunshine Products' average media sentiment score of 0.75 beat Medifast's score of -1.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Overall Sentiment
Medifast Negative
Nature's Sunshine Products Positive

Medifast currently has a consensus price target of $12.00, indicating a potential upside of 14.54%. Nature's Sunshine Products has a consensus price target of $35.00, indicating a potential upside of 66.75%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Medifast.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Medifast has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

95.5% of Medifast shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nature's Sunshine Products has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifast$385.79M0.30-$18.67M-$1.83N/A
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.08

Summary

Nature's Sunshine Products beats Medifast on 14 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Veru?

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M2.86-$22.73M-$0.89N/A
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.08

47.2% of Veru shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 14.2% of Veru shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nature's Sunshine Products has a net margin of 4.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 14.67% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -54.72% -39.09%
Nature's Sunshine Products 4.06%14.67%9.27%

Veru currently has a consensus price target of $23.00, indicating a potential upside of 664.12%. Nature's Sunshine Products has a consensus price target of $35.00, indicating a potential upside of 66.75%. Given Veru's higher probable upside, equities research analysts clearly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Veru has a beta of -1.14, meaning that its stock price is 214% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

In the previous week, Nature's Sunshine Products had 3 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 1 mentions for Veru. Veru's average media sentiment score of 1.89 beat Nature's Sunshine Products' score of 0.75 indicating that Veru is being referred to more favorably in the media.

Company Overall Sentiment
Veru Very Positive
Nature's Sunshine Products Positive

Summary

Nature's Sunshine Products beats Veru on 11 of the 16 factors compared between the two stocks.

Get Nature's Sunshine Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NATR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NATR vs. The Competition

MetricNature's Sunshine ProductsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$369.11M$3.02B$6.81B$12.17B
Dividend YieldN/A1.78%2.68%5.90%
P/E Ratio19.0819.2725.7924.20
Price / Sales0.75329.35548.6394.36
Price / Cash9.6056.5346.3353.91
Price / Book2.274.2210.776.37
Net Income$19.52M$64.45M$3.57B$337.69M
7 Day Performance4.32%2.25%3.15%-0.30%
1 Month Performance-4.11%1.75%2.34%0.37%
1 Year Performance47.09%26.64%33.41%26.93%

Nature's Sunshine Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NATR
Nature's Sunshine Products
3.7821 of 5 stars
$20.99
+1.5%
$35.00
+66.7%
+39.3%$369.11M$489.79M19.08850
HLF
Herbalife
4.2931 of 5 stars
$12.25
+1.0%
$17.80
+45.3%
+45.9%$1.26B$5.04B5.378,500
USNA
USANA Health Sciences
2.5759 of 5 stars
$19.31
+2.2%
N/A-35.8%$348.95M$925.26M41.091,570
NUS
Nu Skin Enterprises
2.3225 of 5 stars
$5.18
+3.6%
N/A-36.3%$242.75M$1.49B4.712,800
MED
Medifast
1.9607 of 5 stars
$10.64
-3.4%
$12.00
+12.8%
-22.5%$122.53M$385.79MN/A870

Related Companies and Tools


This page (NASDAQ:NATR) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners